warfarin and Carcinoma--Signet-Ring-Cell

warfarin has been researched along with Carcinoma--Signet-Ring-Cell* in 2 studies

Other Studies

2 other study(ies) available for warfarin and Carcinoma--Signet-Ring-Cell

ArticleYear
Acute aortic thrombosis during cisplatin based chemotherapy for gastric cancer.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:9

    The development of aortic thrombosis without the presence of atheroscrelosis, dissection, or aneurysms is rare. A cancer-related hypercoagulable state is a well-known risk factor for venous thrombosis, however, atrial thrombosis has rarely been reported in cancer patients. Cisplatin-based chemotherapy is known to cause various side-effects. Detecting aortic thrombosis is important because it is a fatal condition. We herein present the first reported case of endo-aortic thrombosis occurring during cisplatin-based chemotherapy for gastric cancer.

    Topics: Acute Disease; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Aortic Diseases; Aortography; Arterial Occlusive Diseases; Carcinoma, Signet Ring Cell; Cisplatin; Dexamethasone; Drug Combinations; Heparin; Humans; Oxonic Acid; Stomach Neoplasms; Tegafur; Thrombosis; Tomography, X-Ray Computed; Warfarin

2013
Malignancy-associated venous thrombosis with concurrent warfarin-induced skin necrosis, venous limb gangrene and thrombotic microangiopathy.
    Thrombosis and haemostasis, 2006, Volume: 95, Issue:6

    Topics: Anticoagulants; Carcinoma, Signet Ring Cell; Female; Gangrene; Heparin, Low-Molecular-Weight; Humans; Lower Extremity; Lymphatic Metastasis; Middle Aged; Necrosis; Neoplasms, Unknown Primary; Purpura, Thrombotic Thrombocytopenic; Skin; Venous Thrombosis; Warfarin

2006